AGM/EGMJun 9, 2026, 04:22 PM
Haemonetics Corporation Announces 2026 Annual Meeting of Shareholders
AI Summary
Haemonetics Corporation has filed its Definitive Proxy Statement for the 2026 Annual Meeting of Shareholders, scheduled for July 24, 2026. The meeting agenda includes the election of eight directors, an advisory vote on executive compensation, ratification of the independent auditor, and approval of amendments to the company's Long-Term Incentive Compensation Plan and Employee Stock Purchase Plan. The company highlights strong fiscal 2026 performance and governance practices.
Key Highlights
- Haemonetics Corporation will hold its 2026 Annual Meeting of Shareholders on Friday, July 24, 2026, at 8:00 A.M. Eastern Time.
- Shareholders will vote on electing eight director nominees for one-year terms.
- The agenda includes an advisory vote on executive compensation.
- Shareholders will vote on ratifying Ernst & Young LLP as the independent registered public accounting firm for fiscal year ending April 3, 2027.
- Approval is sought for amendments to the 2019 Long-Term Incentive Compensation Plan and the 2007 Employee Stock Purchase Plan.
Price Impact
More from HAE